These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 2884936)
1. Sulphasalazine in rheumatoid arthritis: desensitising the patient with a skin rash. Farr M; Bacon PA Ann Rheum Dis; 1987 May; 46(5):421. PubMed ID: 2884936 [No Abstract] [Full Text] [Related]
2. Sulphasalazine in rheumatoid arthritis: desensitising the patient with a skin rash. Bax DE; Amos RS Ann Rheum Dis; 1986 Feb; 45(2):139-40. PubMed ID: 2868699 [TBL] [Abstract][Full Text] [Related]
3. Sulphasalazine desensitisation in patients with arthritis. McCarthy C; Coughlan R Ir J Med Sci; 1994 May; 163(5):238-9. PubMed ID: 7913919 [TBL] [Abstract][Full Text] [Related]
4. Psoriasis-like skin reaction in a patient with rheumatoid arthritis after sulphasalazine therapy. Bliddal H; Stangerup M Clin Rheumatol; 1991 Jun; 10(2):178-80. PubMed ID: 1680596 [TBL] [Abstract][Full Text] [Related]
5. Fatal neutropenic enterocolitis associated with sulphasalazine therapy for rheumatoid arthritis. Chakravarty K; Scott DG; McCann BG Br J Rheumatol; 1992 May; 31(5):351-3. PubMed ID: 1349846 [TBL] [Abstract][Full Text] [Related]
8. Sulphasalazine desensitisation in rheumatoid arthritis. Farr M; Scott DL; Bacon PA Br Med J (Clin Res Ed); 1982 Jan; 284(6309):118. PubMed ID: 6119134 [No Abstract] [Full Text] [Related]
9. Macrocytic anaemia in patients treated with sulphasalazine for rheumatoid arthritis. Greaves M; Amos RS; Bax D Br Med J (Clin Res Ed); 1987 Feb; 294(6568):373. PubMed ID: 2880620 [No Abstract] [Full Text] [Related]
10. The three week sulphasalazine syndrome. Brooks H; Taylor HG; Nichol FE Clin Rheumatol; 1992 Dec; 11(4):566-8. PubMed ID: 1362531 [TBL] [Abstract][Full Text] [Related]
11. Acute alveolitis and sulphasalazine in rheumatoid arthritis. Geborek P; Monti M; Sandblad F; Wollheim FA Clin Exp Rheumatol; 1984; 2(3):279-80. PubMed ID: 6152205 [No Abstract] [Full Text] [Related]
12. Toxicity of sulphasalazine in rheumatoid arthritis. Possible protective effect of rheumatoid factors and corticosteroids. Gran JT; Myklebust G Scand J Rheumatol; 1993; 22(5):229-32. PubMed ID: 7901898 [TBL] [Abstract][Full Text] [Related]
13. Ten years of sulphasalazine use in rheumatoid arthritis. McConkey B Br J Rheumatol; 1989 Apr; 28(2):175-6. PubMed ID: 2565130 [No Abstract] [Full Text] [Related]
14. Macrocytosis and sulphasalazine treatment of rheumatoid arthritis. Ralston SH; Willocks LJ; Shaw RW; Pitkeathly DA Br J Rheumatol; 1987 Dec; 26(6):472-3. PubMed ID: 2891393 [No Abstract] [Full Text] [Related]
16. Sulphasalazine induced agranulocytosis in a patient with rheumatoid arthritis. Murphy PT; O'Donnell JR Ir J Med Sci; 1990 Jun; 159(6):195. PubMed ID: 1977725 [No Abstract] [Full Text] [Related]
17. Neutropenia in patients with rheumatoid arthritis, treated with sulphasalazine. Marouf ES; Morris IM Br J Rheumatol; 1990 Oct; 29(5):407-9. PubMed ID: 1977490 [No Abstract] [Full Text] [Related]
18. Sulphasalazine in the treatment of rheumatoid arthritis: a renewed challenge. van Riel PL; van de Putte LB Neth J Med; 1990 Jun; 36(5-6):221-2. PubMed ID: 1975649 [No Abstract] [Full Text] [Related]
19. Sulphasalazine therapy in rheumatoid arthritis. A two-year study and follow-up of clinical results. Georgescu C Rom J Intern Med; 1992; 30(2):127-32. PubMed ID: 1353901 [TBL] [Abstract][Full Text] [Related]
20. [Experience with sulphasalazine (salazopyrin) in the treatment of rheumatoid arthritis]. Winkler V Orv Hetil; 1986 Aug; 127(34):2073-4, 2079-80. PubMed ID: 2876405 [No Abstract] [Full Text] [Related] [Next] [New Search]